Guidelines for treatment of HIV infected adults in Europe
Switch to TAF did not affect central nervous system (CNS) HIV infection
20 HIV-infected patients on suppressive antiretroviral treatment
who switched their backbone treatment from emtricitabine/
tenofovir disoproxil fumarate (FTC/TDF) or abacavir/
lamivudine (ABC/3TC) to FTC/tenofovir alafenamide (TAF)
were evaluated for changes in their central nervous HIVinfections.
EACS Guidelines
Magazine